Yelda Serinagaoglu

Mice Lacking Dystrophin or α Sarcoglycan Spontaneously Develop Embryonal Rhabdomyosarcoma with Cancer-Associated p53 Mutations and Alternatively Spliced or Mutant Mdm2 Transcripts

Karen S. Fernández, Yelda Serinagaoglu, Sue Hammond et al. · American Journal Of Pathology · 2009 · 47 citations · Full text

Medicine, Molecular Genetics, Oncology +12

Nf2–Yap signaling controls the expansion of DRG progenitors and glia during DRG development

Yelda Serinagaoglu, Joshua Paré, Marco Giovannini et al. · Developmental Biology · 2014 · 33 citations · Full text

Life Sciences, Developmental Biology, Neuroscience +16

Deletion of Galgt2 (B4Galnt2) Reduces Muscle Growth in Response to Acute Injury and Increases Muscle Inflammation and Pathology in Dystrophin-Deficient Mice

Rui Xu, Neha Singhal, Yelda Serinagaoglu et al. · American Journal Of Pathology · 2015 · 26 citations · Full text

Life Sciences, Cell Biology, Physiology +14

Sensorimotor enhancement in mouse mutants lacking the Purkinje cell-specific Gi/o modulator, Pcp2(L7)

Emilia Iscru, Yelda Serinagaoglu, Karl Schilling et al. · Molecular and Cellular Neuroscience · 2008 · 25 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

A promoter element with enhancer properties, and the orphan nuclear receptor RORα, are required for Purkinje cell-specific expression of a Gi/o modulator

Yelda Serinagaoglu, Rui Zhang, Yufang Zhang et al. · Molecular and Cellular Neuroscience · 2007 · 18 citations

Medicine, Genetics, Molecular Genetics +17